Explore key questions on contamination control strategies to support regulatory compliance and risk management in ...

After years of pouring billions into research and development, China's pharmaceutical sector is finally reaping the rewards. As the 2025 annual reporting season unfolds — from traditional ...

Viatris and Teva Pharmaceutical Industries recently launched separate recalls in the U.S. related to dissolution problems for a common anxiety medication and concerns around an unapproved raw material ...

The pharmaceutical industry is undergoing significant transformations, driven by both innovation and regulatory scrutiny. As we approach mid-April 2026, three critical developments are shaping the ...

With Daiichi Sankyo’s priorities increasingly tied to its innovative medicines—and its oncology portfolio in particular—the Tokyo-based drugmaker is following in the footsteps of several of its peers ...

Pharmaceutical Research and Manufacturers of America President and CEO Steve Ubl plans to step down at the end of 2026. Steve Ubl has led PhRMA, the largest pharmaceutical lobbying group in the ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), announced today that Yannis Morel, Chief Operating Officer, will present at the AACR Oncology Industry Partnering ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), announced today that Yannis Morel, Chief Operating Officer, will ...

A temporary de-escalation may reopen Hormuz transit, but unclear enforcement mechanisms and divergent U.S.–Iran messaging limit confidence in rapid normalization of maritime flows. Petroleum transport ...